{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-017445","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2022-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.179552+00:00","generated_at":"2026-06-25T00:07:24.053098+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Provectus provides annual meeting update on clinical and corporate activities; no specific results disclosed","bullets":["Annual stockholders meeting held on June 22, 2022.","Presentation covered clinical development, regulatory, drug discovery, manufacturing, IP, and business development.","No earnings, revenue, or clinical trial data were reported in the 8-K or exhibit summary.","Presentation slides furnished as Exhibit 99.1, not filed or incorporated by reference."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-017445","json":"https://secwatch.observer/filing/0001493152-22-017445.json","markdown":"https://secwatch.observer/filing/0001493152-22-017445.md","text":"https://secwatch.observer/filing/0001493152-22-017445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000149315222017445/0001493152-22-017445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000149315222017445/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:07:24.053098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}